Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration (AMD)”

377 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 377 results

Large-scale testing (Phase 3)Ended earlyNCT01944839
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 619
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230537
What this trial is testing

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 168
Testing effectiveness (Phase 2)Study completedNCT03211234
What this trial is testing

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 76
Large-scale testing (Phase 3)UnknownNCT03609307
What this trial is testing

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 40
Not applicableStudy completedNCT03803631
What this trial is testing

CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)

Who this might be right for
AMDExudative Macular Degeneration
Centre Hospitalier Intercommunal Creteil 49
Early research (Phase 1)UnknownNCT00767949
What this trial is testing

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Lpath, Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Not applicableActive Not RecruitingNCT07390253
What this trial is testing

Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Vienna Institute for Research in Ocular Surgery 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Not applicableStudy completedNCT01773954
What this trial is testing

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationMacular Degeneration
MidAtlantic Retina 40
Early research (Phase 1)Not Yet RecruitingNCT05611424
What this trial is testing

Gene Therapy for Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Frontera Therapeutics 18
Not applicableLooking for participantsNCT06859515
What this trial is testing

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 42
Testing effectiveness (Phase 2)Study completedNCT03558074
What this trial is testing

Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Alkahest, Inc. 26
Early research (Phase 1)Enrolling By InvitationNCT06737354
What this trial is testing

Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).

Who this might be right for
nAMD
InnoVec Biotherapeutics Inc. 18
Not applicableStudy completedNCT02279537
What this trial is testing

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

Who this might be right for
Wet Macular Degeneration
Bayer 593
Early research (Phase 1)Study completedNCT02204683
What this trial is testing

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Macular Degeneration
University of Nebraska 5
Not applicableStudy completedNCT05111743
What this trial is testing

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 9,261
Not applicableNot Yet RecruitingNCT06759597
What this trial is testing

The Effect of Phacoemulsification on the Macular Changes in Patients with Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (wet) Age-Related Macular Degeneration
Assiut University 50
Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Testing effectiveness (Phase 2)Looking for participantsNCT07630649
What this trial is testing

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Adverum Biotechnologies, Inc. 15
Next Page